An Indian-origin woman who was given just months to live a few years ago is celebrating on Monday after doctors say she is showing no evidence of breast cancer following a clinical trial at a UK hospital.
Two-year trial at the National Institute for Health and Care Research (NIHR) Manchester Clinical Research Facility (CRF) at Christie NHS Foundation Trust involved an experimental medicine combined with Atezolizumab, an immunotherapy drug administered intravenously which she continues to have every three weeks.
Read More at : Indian-origin woman given two months to live, beats cancer after UK drug trial (msn.com)